Since the landmark discovery in 1993 that mutations in the Cu/Zn superoxide dismutase 1 (SOD1) gene cause the familial form of ALS (FALS; Rosen et al., 1993), the underlying molecular features, and associated clinical characteristics of this disease have been extensively annotated. Here, SOD1 is linked to amyotrophic lateral sclerosis.